% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • thirdmeinvestor thirdmeinvestor Feb 26, 2013 4:56 PM Flag

    VERTEX begins the PHASE III trial for F508del CF with VX-809/770

    Vertex Announced Initiation of pivotal Phase 3 Program of VX-809 in
    Combination with Ivacaftor for the Treatment of People with Cystic Fibrosis
    Who Have homozygous F508del Mutation.

    Apparently the FDA agreed to the trial design.

125.803-0.997(-0.79%)1:29 PMEDT